PET is a functional imaging method that can exploit various aspects of tumor biology to
enable greater detection of prostate cancer than can be provided by morphologic imaging …

Purpose: The summary presented herein represents Part I of the three-part series dedicated
to Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, discussing risk assessment …

Importance The presence of pelvic nodal metastases at radical prostatectomy is associated
with biochemical recurrence after prostatectomy. Objective To assess the accuracy of …

Prostate cancer is a very heterogeneous disease, and contemporary management is
focused on identification and treatment of the prognostically adverse high-risk tumors while …

Purpose To compare the diagnostic efficiency of 68 Gallium labelled prostate-specific
membrane antigen positron emission tomography (68 Ga-PSMA PET) and magnetic …

Context The clinical introduction of next-generation imaging methods and molecular
biomarkers (“radiogenomics”) has revolutionized the field of prostate cancer (PCa). While …

Context Management of newly diagnosed prostate cancer (PCa) is guided in part by
accurate clinical staging. The role of imaging, including magnetic resonance imaging (MRI) …

Simple Summary Oligometastatic prostate cancer has classically been defined as a small
volume of prostate cancer spread as defined by imaging using CT, MRI, and bone scans …

Trans-1-amino-3-18F-fluorocyclobutanecarboxylic-acid (anti-[18F]-FACBC) has been
approved for the detection of prostate cancer (PCa) in patients with elevated prostate …

Simple Summary Accurate primary staging for determining the extent of prostate cancer is
crucial for planning treatment in high-risk patients for distant metastases. Recurrence is still …